Healthcare :: Quality of treatment guidelines

Practising physicians are nowadays presented with official guidelines on the treatments they should give their patients. In an article published in PLoS Medicine, researchers have attempted to grade the quality of evidence used in drawing up the recommendations contained in guidelines for the treatment of patients with diabetes, high blood pressure and dyslipidemia (abnormal levels of fats in the blood).

Breast Implants :: Breast implants linked to higher long-term suicide risk

The long-term risk of suicide is tripled for women who have undergone cosmetic breast implant surgery, concludes a study in the August Annals of Plastic Surgery, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. This long-term study further confirms the link between breast implants and a strikingly high risk of suicide and other related causes of death.

Influenza :: Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks

An analysis of non-pharmaceutical interventions used in the U.S. during the 1918-1919 influenza pandemic, such as closing schools and banning public gatherings, found an association between these interventions and reduced death rates, suggesting that non-pharmaceutical interventions may play a role in planning for future influenza pandemics, according to a study in the August 8 issue of JAMA.

Cancer :: Health Canada approves Sativex for cancer pain

GW Pharmaceuticals plc (AIM: GWP) and Bayer Inc., a subsidiary of Bayer AG, announce that Health Canada has approved Sativex?, a cannabis derived pharmaceutical treatment, as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain.

HIV :: FDA approves antiretroviral drug Maraviroc for HIV patients

The U.S. Food and Drug Administration (FDA) approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.

Skin :: New technologies tighten skin from head to toe without surgery

If sagging skin is getting you down, recent advances in skin-tightening technologies can lift your spirits ? and your skin ? in a matter of a few office visits to your dermatologist. The beauty of these non-invasive procedures is their ability to treat loose skin virtually anywhere on the body without the risks and downtime associated with surgery.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack